Purpose: Intracystic papillary breast tumors consist of benign papilloma, carcinoma in situ and carcinoma with invasion. Using high-density single-nucleotide polymorphism arrays, this study aimed to determine the profile of genomic alterations in these lesions and to identify novel diagnostic criteria. Methods: Ten samples of intracystic papillary tumor, which included five papillomas (Pap), three papillary carcinomas in situ (PurePC) and two papillary carcinomas with invasion (PCinv), were studied. DNA was extracted from tumor and normal tissues that were microdissected from the same formalin-fixed paraffin embedded blocks. Using probe intensity and genotype data from high-density oligonucleotide SNP microarrays (AffymetrixR GeneChip Genom...
Introduction. Breast papillary lesions represent a heterogeneous group of tumors ranging from benign...
Purpose:; Lobular carcinoma; in situ; (LCIS) is a preinvasive lesion of the breast. We sought to def...
BACKGROUND: Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. In...
Purpose: Intracystic papillary breast tumors consist of benign papilloma, carcinoma in situ and carc...
Background: Even after needle biopsy, the preoperative differential diagnoses of intracystic tumors ...
The purpose of this study was to use comparative genomic hybridization (CGH) to screen breast tumors...
Array comparative genomic hybridization (CGH) has been popularly used for analyzing DNA copy number ...
BACKGROUND:Ductal carcinoma in situ (DCIS) of the breast is heterogeneous in terms of the risk of pr...
INTRODUCTION: Breast papillary lesions represent a heterogeneous group of tumors ranging from benign...
Intra-ductal papillomas (IDP) are challenging breast findings because of their variable risk of prog...
Objectives. The chief goal of this study was to analyze copy number variation (CNV) in breast cancer...
Multiple environmental and genetic factors are involved with the development of basal cell\ud carcin...
Genomic DNA copy number alterations are key genetic events in the development and progression of hum...
Breast cancer (BC) patient management has been transformed over the last two decades due to the deve...
Micropapillary carcinoma (MPC) is a rare histological special type of breast cancer, characterized b...
Introduction. Breast papillary lesions represent a heterogeneous group of tumors ranging from benign...
Purpose:; Lobular carcinoma; in situ; (LCIS) is a preinvasive lesion of the breast. We sought to def...
BACKGROUND: Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. In...
Purpose: Intracystic papillary breast tumors consist of benign papilloma, carcinoma in situ and carc...
Background: Even after needle biopsy, the preoperative differential diagnoses of intracystic tumors ...
The purpose of this study was to use comparative genomic hybridization (CGH) to screen breast tumors...
Array comparative genomic hybridization (CGH) has been popularly used for analyzing DNA copy number ...
BACKGROUND:Ductal carcinoma in situ (DCIS) of the breast is heterogeneous in terms of the risk of pr...
INTRODUCTION: Breast papillary lesions represent a heterogeneous group of tumors ranging from benign...
Intra-ductal papillomas (IDP) are challenging breast findings because of their variable risk of prog...
Objectives. The chief goal of this study was to analyze copy number variation (CNV) in breast cancer...
Multiple environmental and genetic factors are involved with the development of basal cell\ud carcin...
Genomic DNA copy number alterations are key genetic events in the development and progression of hum...
Breast cancer (BC) patient management has been transformed over the last two decades due to the deve...
Micropapillary carcinoma (MPC) is a rare histological special type of breast cancer, characterized b...
Introduction. Breast papillary lesions represent a heterogeneous group of tumors ranging from benign...
Purpose:; Lobular carcinoma; in situ; (LCIS) is a preinvasive lesion of the breast. We sought to def...
BACKGROUND: Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. In...